Simulations Plus has announced strategic partnership programmes with three pharmaceutical businesses to advance AI-enabled modelling in drug development. The partnerships aim to apply AI within ...

• Existing uses and current efficiencies: Artificial intelligence, including generative AI, is enhancing efficiency and effectiveness in trial design, patient recruitment and drug manufacturing, and ...

OpenAI has unveiled GPT‑Rosalind, its first AI model tailored for life sciences, aimed at accelerating research in biology, drug discovery, and translational medicine. Named after DNA pioneer Rosalind ...

Oncologic drug development needs to place a greater focus on the patient, according to a commentary in the current issue of the New England Journal of Medicine. Even though the US Food and Drug ...

Sriram Krishnan, Ph.D., Chief Product Officer at Target RWE; 20+ years building health tech, inventor on 28 patents, author of 30+ papers. As the chief product officer at Target RWE, a health ...